Clal Biotechnology Industries Ltd. (TLV:CBI)

Market Cap	46.58M
Revenue (ttm)	n/a
Net Income (ttm)	-62.46M
Shares Out	156.85M
EPS (ttm)	-0.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	883,365
Average Volume	282,251
Open	29.70
Previous Close	29.70
Day's Range	29.70 - 29.80
52-Week Range	28.20 - 52.50
Beta	0.65
RSI	36.57
Earnings Date	n/a

About TLV:CBI

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through per...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: CBI